Table 1.

Disorders included in the Philippine Expanded Newborn Screening Program.

Disorder Group	Disorder(s)	Abbreviation
Endocrine	Primary Congenital Hypothyroidism	CH
	Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency)	CAH
Amino Acid	Homocystinuria	HCY
	Methionine Adenosine Transferase Deficiency (Hypermethioninemia)	MAT
	Maple Syrup Urine Disease	MSUD
	Phenylketonuria	PKU
	a Tyrosinemia Type I, II, III	TYR
Fatty Acid Oxidation	Carnitine Palmitoyltransferase I Deficiency	CPT1
	Carnitine Palmitoyltransferase II Deficiency	CPT2
	Carnitine Uptake Deficiency	CUD
	Glutaric Acidemia Type II	GA II
	Long Chain Hydroxyacyl-CoA Dehydrogenase Deficiency	LCHAD
	Medium Chain-Acyl-CoA Dehydrogenase Deficiency	MCAD
	Very Long Chain-Acyl-CoA Dehydrogenase Deficiency	VLCAD
	Tri-functional Protein Deficiency	TFP
Organic Acid	3-Methylcrotonyl CoA Carboxylase Deficiency	3MCC
	Beta Ketothiolase Deficiency	BKT
	Glutaric Acidemia Type I	GA1
	Isovaleric Acidemia	IVA
	Methylmalonic Acidemia	MMA
	Multiple Carboxylase Deficiency	MCD
	Propionic Acidemia	PA
Urea Cycle	Citrullinemia	CIT
	Argininosuccinic Aciduria	ASA
Hemoglobin	All Detectable Hemoglobinopathies and Thalassemias	HGB
Other	Galactosemia	GAL
	Glucose-6-Phosphate Dehydrogenase Deficiency	G6PDD
	Cystic Fibrosis	CF
	Biotinidase Deficiency	BIO

^a Screening methodology includes screening for both succinyl acetone and tyrosine.